Untitled

Download a copy of this content.

Access the recording.

HealthTrust presents…”2018 Updates in Acute Ischemic Stroke Management”

Stroke is the fifth leading cause of mortality in the United States, and the leading cause of disability. Timely therapy, including pharmacotherapy for eligible patients, is essential to reducing morbidity and mortality in stroke patients. Pharmacists in the acute care setting can play an integral role in assessing patients for eligibility and facilitating timely stroke pharmacotherapy. In 2018, The American Heart Association/American Stroke Association updated their 2013 guideline recommendations for the early management of acute ischemic stroke (AIS). This session will discuss the role of the pharmacist in applying the updated recommendations for fibrinolytic, antihypertensive and antiplatelet therapy for Acute Ischemic Stroke (AIS) to optimize patient care and clinical outcomes. Additionally, this session will give an overview on the latest recommendations for nonpharmacologic therapy for AIS.

Learning Objectives for Pharmacists  |  At the end of this session, participants should be able to:

1.  Identify the pharmacist’s role in the management of patients with acute ischemic stroke (AIS).
2. Discuss the updated recommendations for the use of systemic fibrinolytic therapy for AIS.
3. Review the updated recommendations for adjunctive and/or alternative pharmacologic and nonpharmacologic therapies for AIS.

Learning Objectives for Pharmacy Technicians  |  At the end of this session, participants should be able to:

1. Recall the difference between hemorrhagic and ischemic strokes.
2. Identify brand and generic drugs names for medications used to treat strokes.

Presenter:

Raghad Saadi, PharmD  |  PGY-2 Emergency Medicine Pharmacy Resident  |  Rutgers University/Robert Wood Johnson University Hospital

Target Audience:  Pharmacists & Pharmacy Techs

Continuing Education Information: 1.0 contact hours approved for Pharmacists and Pharmacy Technicians. Belmont University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The ACPE Universal Activity Numbers for this activity are 0863-9999-19-037-L01-P and 0863-9999-19-037-L01-T . The activity will provide 1 hour (.1 CEUs) of continuing education credit to pharmacists and pharmacy technicians who attend the webinar and complete the online evaluation.

Note about CE credit: If you plan to obtain credit, stay until the end of the presentation to receive the verification code you will need to obtain your continuing education credit. A reminder that CE credit is individual. No group credit is available. Each person must register for this session and attend the webinar for 40 minutes or longer in order to receive an email after the event with instructions on how to apply for continuing education credit. Please do not share the code or forward the email you receive to others who did not actually attend the program. If they are not able to be verified on our webinar provider reports and registration list they will not receive credit. Also, please note: If you are joining only by phone, you will not be eligible for credit. You must also log in and join the visual portion of the webinar to be part of our CE provider-required reporting.

A participant, sponsor, faculty member or other individual wanting to file a grievance with respect to any aspect of a program sponsored or co-sponsored by the Belmont COP may contact the Dean of Belmont University College of Pharmacy in writing at david.gregory@belmont.edu. The grievance will be reviewed and a response will be returned within 45 days of receiving the written statement. If not satisfied, an appeal to the Dean of the College of Pharmacy can be made for a second level of review.